METASTASES TO PITUITARY GLAND

METASTASES TO PITUITARY GLAND was reported 45 times

METASTASES TO PITUITARY GLAND is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Ergot Derivative [EPC] 1 0.0002
1 Estrogen Receptor Antagonist [EPC] 5 0.0001
2 HER2/neu Receptor Antagonist [EPC] 6 0.0001
3 Radioligand Therapeutic Agent [EPC] 1 0.0001
4 Programmed Death Receptor-1 Blocking Antibody [EPC] 5 0.0001
5 Microtubule Inhibitor [EPC] 8 0.0000
6 RANK Ligand Inhibitor [EPC] 9 0.0000
7 CTLA-4-directed Blocking Antibody [EPC] 2 0.0000
8 Androgen [EPC] 1 0.0000
9 Aromatase Inhibitor [EPC] 3 0.0000
10 Topoisomerase Inhibitor [EPC] 2 0.0000
11 Platinum-based Drug [EPC] 5 0.0000
12 Alkylating Drug [EPC] 4 0.0000
13 Nucleoside Metabolic Inhibitor [EPC] 4 0.0000
14 Cardiac Glycoside [EPC] 1 0.0000
15 Androgen Receptor Inhibitor [EPC] 1 0.0000
16 Kinase Inhibitor [EPC] 7 0.0000
17 Vascular Endothelial Growth Factor Inhibitor [EPC] 2 0.0000
18 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
19 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
20 Corticosteroid [EPC] 10 0.0000
21 Aldosterone Antagonist [EPC] 1 0.0000
22 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
23 HMG-CoA Reductase Inhibitor [EPC] 2 0.0000
24 Thiazide Diuretic [EPC] 1 0.0000
25 Proton Pump Inhibitor [EPC] 2 0.0000
26 Benzodiazepine [EPC] 2 0.0000
27 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
28 Insulin Analog [EPC] 1 0.0000
29 Loop Diuretic [EPC] 1 0.0000
30 Platelet Aggregation Inhibitor [EPC] 1 0.0000
31 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000